Brevetti
Brevetti
-
Brevetto EP3512835, a A Process For Purification of Carfilzomib Intermediate.
-
Brevetto 102015000040461, Composizione e metodo per promuovere la crescita di piante erbacee e favorire un accumulo di sostanza organica nel terreno.
-
Brevetto US10253066, A Process For Purification of Carfilzomib.
-
Brevetto US9688625, AMORPHOUS FORM OF A THIOCOLCHICINE DERIVATIVE.
-
Brevetto US10414829, An Improved Process For The Preparation of Sugammadex And Its Intermediates.
-
Brevetto US10414830, Crystalline Forms Of Per-chloro-gamma-cyclodextrines.
-
Brevetto US 08771642, Active particles for bio-analytical applications and methods for their preparation.
-
Brevetto US 8735475 B2, Inhibitor combination, resin mixture containing same and use of same.
-
Brevetto PCT/IB2014/061230, Method for controlling solubility of quantum dots.
-
Brevetto WO2015007706A1, Fluoropolymer fibre.
-
Brevetto WO 2014207655, Method for producing, from a polymer matrix in a liquid phase, a solid material containing nano-additives.
-
Brevetto US9586919, A CRYSTALLINE ANHYDROUS FORM OF CABAZITAXEL, PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF.
-
Brevetto RM2013A000269, Method for controlling solubility of quantum dots.
-
Brevetto BO2013A000334, METODO PER LA REALIZZAZIONE DI UN MATERIALE SOLIDO NANOADDITIVATO A PARTIRE DA UNA MATRICE POLIMERICA IN FASE LIQUIDA.
-
Brevetto WO2014024106 (A1), METHOD FOR THE PRODUCTION OF THERMOCHEMILUMINESCENT SILICA NANOPARTICLES AND THEIR USE AS MARKERS IN BIOANALYTIC METHODS.
-
Brevetto WO2015058960, Crystalline solvate forms of cabazitaxel.
-
Brevetto EP2743264, New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof.
-
Brevetto DE102011077254 (B3), Verwendung einer Inhibitorkombination, Harzmischung, Reaktionsharzmörtel, Zweikomponenten - Mörtelsystem und dessen Verwendung sowie Patrone, Kartusche oder Folienbeutel enthaltend ein Zweikomponenten - Mörtelsystem.
-
Brevetto EP 2495235 A1 20120905, Process for the synthesis of prostaglandins and intermediates thereof.